Chromogenic Substrates

Chromogenic substrates are compounds that produce a visible color change when acted upon by specific enzymes. These substrates are widely used in diagnostic assays, biochemical research, and enzyme-linked immunosorbent assays (ELISAs) to detect and quantify enzyme activity. The color change allows for easy and rapid visual identification of enzyme reactions, making chromogenic substrates essential tools in laboratory analysis. At CymitQuimica, we provide a diverse selection of high-quality chromogenic substrates to support your research and diagnostic applications.

20
- 50
- 100
- 200

products per page. 790 products on this category.

Product data	Purity	Price range	Estimated delivery
5-Bromo-4-chloro-3-indoxyl-α-L-arabinopyranoside REF: 3D-B-7046	- - -	To inquire	Tue 10 Dec 24
4-(Bromomethyl)phenyl-β-D-triacetylglucuronic acid methyl ester REF: 3D-B-8898	Min. 95 Area-%	To inquire	Tue 10 Dec 24
Aldol® 495 β-D-glucuronic acid, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4752_P00CAS: 2484873-00-7	Min. 95.0 Area-%	To inquire	Tue 10 Dec 24
Aldol® 515 nonanoate hydrochloride, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4774_P00CAS: 2484873-13-2	Min. 95 Area-%	To inquire	Tue 10 Dec 24
5-Bromo-4-chloro-3-indoxyl-α-D-galactopyranoside REF: 3D-B-7141CAS: 107021-38-5	Min. 99 Area-%	To inquire	Tue 10 Dec 24
Aldol® 455 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4689_P00CAS: 1318785-27-1	Min. 92.0 Area-%	To inquire	Tue 10 Dec 24
5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, cyclohexylammonium salt monohydrate REF: 3D-B-7300CAS: 114162-64-0	Min. 99.0 Area-%	To inquire	Tue 10 Dec 24
5-Bromo-4-chloro-3-indoxyl-β-D-fucopyranoside REF: 3D-B-7136CAS: 17016-46-5	Min. 99.0 Area-%	To inquire	Tue 10 Dec 24
Aldol® 515 caprylate hydrochloride REF: 3D-A-4781_P00CAS: 2484873-14-3	Min. 95 Area-%	To inquire	Tue 10 Dec 24
Aldol® 584 β-D-glucuronic acid, triethylammonium salt, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4768_P00CAS: 2484873-11-0	Min. 95.0 Area-%	To inquire	Tue 10 Dec 24
5-Bromo-4-chloro-3-indoxyl phosphate, p-toluidine salt, high grade REF: 3D-B-7500CAS: 6578-06-9	Min. 98.0 Area-%	To inquire	Tue 10 Dec 24
Aldol® 455 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4684_P00CAS: 1254797-99-3	Min. 93.0 Area-%	To inquire	Tue 10 Dec 24
5-Bromo-4-chloro-3-indoxyl thymidine-3'-phosphate, cyclohexylammonium salt REF: 3D-B-7680CAS: 341973-00-0	Min. 98 Area-%	To inquire	Tue 10 Dec 24
5-Bromo-4-chloro-3-indoxyl-β-D-glucopyranoside REF: 3D-B-7250CAS: 15548-60-4	Min. 98.0 Area-%	To inquire	Tue 10 Dec 24
Aldol® 458 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4691_P00CAS: 1254797-77-7	Min. 95.0 Area-%	To inquire	Tue 10 Dec 24
Aldol® 495 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4701_P00CAS: 1254798-26-9	Min. 95.0 Area-%	To inquire	Tue 10 Dec 24
6-Bromo-2-naphthyl-α-D-galactopyranoside REF: 3D-B-8925CAS: 25997-59-5	Min. 98 Area-%	To inquire	Tue 10 Dec 24
5-Bromo-4-chloro-3-indoxyl-α-D-fucopyranoside REF: 3D-B-7134CAS: 1301706-80-8	- - -	To inquire	Tue 10 Dec 24
Aldol® 515 acetate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4673_P00CAS: 2484872-46-8	Min. 95.0 Area-%	To inquire	Tue 10 Dec 24
Aldol® 495 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4715_P00CAS: 2484873-16-5	Of Solute (Hplc) 95.0 To 100.0 Area-%	To inquire	Tue 10 Dec 24

1g		To inquire
100mg		To inquire
250mg		To inquire
500mg		To inquire
2500mg		To inquire

1g		To inquire
50mg		To inquire
100mg		To inquire
250mg		To inquire
500mg		To inquire

Chromogenic Substrates

5-Bromo-4-chloro-3-indoxyl-α-L-arabinopyranoside

Ref: 3D-B-7046

4-(Bromomethyl)phenyl-β-D-triacetylglucuronic acid methyl ester

Ref: 3D-B-8898

Aldol® 495 β-D-glucuronic acid, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4752_P00

Aldol® 515 nonanoate hydrochloride, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4774_P00

5-Bromo-4-chloro-3-indoxyl-α-D-galactopyranoside

Ref: 3D-B-7141

Aldol® 455 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4689_P00

5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, cyclohexylammonium salt monohydrate

Ref: 3D-B-7300

5-Bromo-4-chloro-3-indoxyl-β-D-fucopyranoside

Ref: 3D-B-7136

Aldol® 515 caprylate hydrochloride

Ref: 3D-A-4781_P00

Aldol® 584 β-D-glucuronic acid, triethylammonium salt, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4768_P00

5-Bromo-4-chloro-3-indoxyl phosphate, p-toluidine salt, high grade

Ref: 3D-B-7500

Aldol® 455 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4684_P00

5-Bromo-4-chloro-3-indoxyl thymidine-3'-phosphate, cyclohexylammonium salt

Ref: 3D-B-7680

5-Bromo-4-chloro-3-indoxyl-β-D-glucopyranoside

Ref: 3D-B-7250

Aldol® 458 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4691_P00

Aldol® 495 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4701_P00

6-Bromo-2-naphthyl-α-D-galactopyranoside

Ref: 3D-B-8925

5-Bromo-4-chloro-3-indoxyl-α-D-fucopyranoside

Ref: 3D-B-7134

Aldol® 515 acetate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4673_P00

Aldol® 495 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4715_P00